No Detail Found!

Serum Adropin level in females with and without metabolic syndrome and its association with metabolic syndrome criteria in Gorgan

Author(s)
Sinan Ahmed Khalaf Metabolic Disorders Research Center, Department of Biochemistry and Biophysics, Gorgan Faculty of Medicine, Golestan University of Medical Sciences, Golestan Province, Gorgan, Iran
Hala Khalil Metabolic Disorders Research Center, Department of Biochemistry and Biophysics, Gorgan Faculty of Medicine, Golestan University of Medical Sciences, Golestan Province, Gorgan, Iran
Mostafa Allahyari Metabolic Disorders Research Center, Department of Biochemistry and Biophysics, Gorgan Faculty of Medicine, Golestan University of Medical Sciences, Golestan Province, Gorgan, Iran
Mahin Tatari Bioistatistics counseling and Reproductive Health Research Center, Golestan University of Medical Sciences, Golestan Province, Gorgan, Iran
Abdoljalal Marjani Metabolic Disorders Research Center, Department of Biochemistry and Biophysics, Gorgan Faculty of Medicine, Golestan University of Medical Sciences, Golestan Province, Gorgan, Iran
Abstract
Metabolic syndrome (MetS), a global public health issue that has become an epidemic over the past several years. Our study assessed to estimate the adropin level in females with and without MetS and its association with MetS criteria in Gorgan. The study enrolled 64 females with MetS and 64 females without MetS. The MetS was defined using Adult Treatment Panel-III (ATP-III) guidelines. There are significant differences in the WC, SBP, DBP, FBG, TG, HDL-C and adropin levels (P<0.05). The percentage of females with one, two, three, more equal and more than four criteria of MetS was 16.40%, 33.60%, 25.78% and 24.22%, respectively. There were significant differences between the groups with one or more MetS criteria. As the number of MetS criteria increased, there were more significant increases in all parameters except HDL-C and adropin. Adropin correlated significantly negatively and positively with FBG and TG and HDL-C of the females with MetS, respectively. Adropin correlated significantly negatively and positively with FBG and TG and HDL-C in females with 3 and =4 MetS criteria, respectively. It can be concluded that adropin is significantly decreased in females with MetS and an increasing number of MetS criteria. Based on its role in metabolic disorders, it may be considered as a risk factor for the development of MetS. Adropin may be suggested as a target treatment for MetS. However, further research is needed to fully understand the relationship between adropin and MetS complications and treatment
Publication Details
Page(s) 879-885
DOI DOI not available
Published Journal: Bioscience Research, Volume: 20, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
MetS, Females, Adropin, Gorgan
0

Citations

0

Downloads

38

Views